Telix Pharmaceuticals Limited TLX
Set alert
9.10 USD -0.41 -4.31%
At close · Oct 30
9.10 0.00 0.00%
After hours · Oct 30, 4:27 PM ET
8.98 Day range 9.26
6.41 52-week range 12.83
- YTD
- +21.50%
- 1 year
- -15.19%
- Open
- 9.26
- Prev close
- 9.51
- Mkt cap
- 3.09B
- Vol
- 341.88K
- Avg vol
- 317.24K
- EPS
- 0.10
- P/E
- 91.00
- Div yield
- 0.00%
More statistics
- Low
- 8.98
- High
- 9.26
- Forward P/E
- -340.70
- Beta
- 0.56
- Short ratio
- 0.76
- Inst. own
- 1.02%
- Dividend
- 0.00
- Ex-div date
- Earnings
- Feb 19, 2027
- 50-d avg
- 11.12
- 200-d avg
- 9.90
- 1y target
- 20.56
Financial health
Altman Z-Score
3.76 Safe zone
Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.
Piotroski F-Score
5 / 9 Average
Nine pass/fail tests of profitability, leverage and efficiency.
FMP rating
C2 / 5 overall
- DCF 1
- Return on Equity 3
- Return on Assets 3
- Debt / Equity 1
- P/E 1
- P/B 1
Valuation
P/E -362×
FY 2016 5y median -67.3× FY 2025
P/S 3.2×
FY 2016 5y median 14.1× FY 2025
P/B 6.1×
FY 2016 5y median 47.7× FY 2025
P/FCF -46.7×
FY 2016 5y median -46.7× FY 2025
EV/EBITDA 54.6×
FY 2016 5y median 54.6× FY 2025
EV/Sales 3.6×
FY 2016 5y median 13.9× FY 2025
FCF Yield -2.1%
FY 2016 5y median -1.0% FY 2025
Profitability
Gross Margin 53.1%
FY 2016 5y median 62.6% FY 2025
Operating Margin 2.2%
FY 2016 5y median 2.2% FY 2025
Net Margin -0.9%
FY 2016 5y median -0.9% FY 2025
ROE -1.7%
FY 2016 5y median -1.7% FY 2025
ROIC 1.8%
FY 2016 5y median 1.8% FY 2025
ROA -0.6%
FY 2016 5y median -0.6% FY 2025
Growth (YoY)
Revenue 0.8%
FY 2016 FY 2025
Operating Income -78.7%
FY 2016 FY 2025
EPS (diluted) -114.8%
FY 2016 FY 2025
Free Cash Flow -289.0%
FY 2016 FY 2025
Financial Health
Current Ratio 1.4×
FY 2016 5y median 1.4× FY 2025
Quick Ratio 1.3×
FY 2016 5y median 1.3× FY 2025
Debt / Equity 1.1×
FY 2016 5y median 1.0× FY 2025
Net Debt / EBITDA 6.2×
FY 2016 5y median 0.3× FY 2025
Interest Coverage 0.5×
FY 2016 5y median 0.5× FY 2025
Dividends
Dividend Yield 0.0%
FY 2016 5y median 0.0% FY 2025
Payout Ratio 0.0%
FY 2016 5y median 0.0% FY 2025
Annual · latest fiscal year ends 2025-12-31